Citadel Advisors
ARDT

Citadel Advisors’s Ardent Health ARDT Stock Holding History

Citadel Advisors’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,900
Closed -$96.2K – 14514
2025
Q4 		$96.2K Sell
10,900
-6,100
-36% -$70.5K ﹤0.01% 11675
2025
Q3 		$225K Buy
+17,000
New +$213K ﹤0.01% 11010
2025
Q2 		– Sell
-5,200
Closed -$71.5K – 15571
2025
Q1 		$71.5K Buy
5,200
+2,800
+117% +$40.9K ﹤0.01% 11885
2024
Q4 		$41K Sell
2,400
-1,400
-37% -$24.3K ﹤0.01% 12597
2024
Q3 		$69.8K Buy
+3,800
New +$67.2K ﹤0.01% 11563

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's ARDT Position: Q2 2026 in Review

Citadel Advisors reduced its Ardent Health (ARDT) stake by 33% in Q2 2026, selling an estimated $526K and leaving 113,495 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7938.

Citadel Advisors first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $18.5M in Q3 2024. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Citadel Advisors held 113,495 shares of Ardent Health worth $1.12M as of Q2 2026.
  • Citadel Advisors sold 55,426 Ardent Health shares in Q2 2026, an estimated $526K.
  • Ardent Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7938 holding.
  • Citadel Advisors first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • Citadel Advisors's Ardent Health position peaked at $18.5M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.